An­oth­er wave of scruti­ny has hit WuXi AppTec through its re-in­clu­sion in the Pen­ta­gon’s up­dat­ed list of com­pa­nies that have ties to the Chi­nese mil­i­tary...

DHL is in dis­cus­sions with mul­ti­ple ma­jor drug­mak­ers who are look­ing for the lo­gis­tics com­pa­ny to ei­ther take over their sites or ac­cess its re­sources...

Neion Bio has se­cured an over­sub­scribed $23 mil­lion Se­ries A to fur­ther de­vel­op its tech­nol­o­gy that us­es chick­en eggs to make ac­tive phar­ma­ceu­ti­cal in­gre­di­ents for...

Plus, news about a drug short­ages re­port and Ax­plo­ra:

🛑 Ca­mu­rus has been hit with a sec­ond CRL: The re­jec­tion is for the drug CAM2029...

Grace Sci­ence ap­peared to be one of the few com­pa­nies fight­ing ul­tra-rare dis­eases whose gene ther­a­py can­di­date might make it across the fin­ish line.

Co-found­ed...

The long-act­ing GLP-1 shot that was the cen­ter­piece of Pfiz­er’s ac­qui­si­tion of Met­sera last year looks ef­fec­tive in pa­tients with both obe­si­ty and di­a­betes, ac­cord­ing...